Stocks
FDA Clears Subcutaneous Leqembi Iqlik for At-Home Use
The FDA has approved Biogen and Eisai's Leqembi Iqlik, a subcutaneous version of their Alzheimer's treatment, for initiation and maintenance dosing, including...
The FDA has approved Biogen and Eisai's Leqembi Iqlik, a subcutaneous version of their Alzheimer's treatment, for initiation and maintenance dosing, including...